GABAPENTIN
NDC 31722-091, GABAPENTIN, tablet, film coated, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-091
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218075
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-091 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN300 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-091-90 | 31722009190 | 90 TABLET, FILM COATED in 1 BOTTLE (31722-091-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0ce53f62-1738-43f4-9a2e-c5dc42a91d09NADAC price for package 31722009190
GET /v1/drugs/nadac/31722009190
Use it
Look up 31722-091 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-091 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-091. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.